# Cochrane

# Trusted evidence.

# Informed decisions.

# Better health.

# Cochrane Database of Systematic Reviews

# NCT04970446 (Continued)

# Interventions

# Experimental arm

• FMT after 1 week of antibiotic therapy

# Control arm

• Placebo liquid formulation after 1 week of antibiotic therapy

# Outcomes

# Primary outcome

• Clinical response (CDAI decrease ≥ 100 or CDAI < 150) at week 8

# Starting date

First posted: 21 July 2021

# Contact information

Amy Wilson O'Brien

Tel: +61430461146; email: amy.wilson-obrien@svha.org.au

# Notes

# NCT04997733

# Study name

Fecal microbiota transplantation in Crohn's disease as relay after anti-TNF withdrawal (MIRACLE)

# Methods

RCT conducted in France

# Participants

# Inclusion criteria

- Age ≥ 18 to < 75 years
- CD diagnosis (according to Lennard-Jones criteria) for ≥ 6 months
- Steroid-free clinical remission for ≥ 6 months with anti-TNF agent (no clinical evidence of flare, no change in CD-specific treatment (anti-TNF, immunosuppressive, etc.) within 6 months before inclusion) and CDAI < 150 the week before inclusion; willingness to withdraw anti-TNF treatment
- Women of childbearing age with active birth control during at least the period of treatment (week 52)
- With health insurance
- Informed written consent

# Exclusion criteria

- CD complication requiring surgical treatment
- Contraindication to colonoscopy or anesthesia
- Pregnancy or lactation (see Addendum 4 in publication)
- Diagnosis of CD restricted to the upper gastrointestinal tract (esophagus, stomach, duodenum, jejunum)
- Active perineal disease (evidence of perineal abscess or active draining fistula or presence of seton or perineal ulceration)
- History of bowel resection
- Current stoma (ileostomy or colostomy) or stoma in the last 6 months; any other intra-abdominal surgery within 3 months prior to inclusion
- Participation in any other interventional study
- People under legal protection

# Fecal transplantation for treatment of inflammatory bowel disease (Review)

Copyright © 2023 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.